HomeMEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

BIOCORP and ROCHE DIABETES CARE FRANCE Launch Mallya, an Innovative Medical Device to Better the Daily Life of Patients With Diabetes

Manufactured in Clermont-Ferrand (France), this innovation for patients taking insulin is the first in its category to receive the CE-mark (medical device).

Nerivio Wearable Migraine Therapeutic Now Eligible for Insurance Coverage through UpScript’s Telemedicine Platform

“It is our mission to make Nerivio accessible to everyone who experiences migraine episodes,” said Theranica CEO Alon Ironi.

Carmafil Launches Newly Designed Guidewire Bowl – Now Commercially Available

Carmafil guidewire bowl was developed by vascular/endovascular neurosurgeon Dr. Cargill Alleyne.

Medtronic Announces Ongoing Initiatives to Address Health Equity for People of Color Living with Diabetes

The company committed investments in partnerships with the American Diabetes Association® (ADA) and T1D Exchange, as well as additional research efforts, to better understand and address these disparities.

The Medtronic Foundation and Children’s Heartlink Focus New Partnership on Health Equity for 10,000 Children and 10,000 Health Workers in Underserved Countries

This partnership continues a rich collaborative legacy across the organizations and is made in honor of Omar Ishrak, former chairman and CEO, Medtronic and former board member of the Medtronic Foundation, a true champion of impact-driven philanthropy focusing on the underserved.

XIENCE Stent Receives European Approval for One-Month Dual Anti-Platelet Therapy (DAPT) for High Bleeding Risk Patients

The approval follows recent results from two studies that demonstrated both one-month or three-month DAPT followed by aspirin monotherapy is safe in HBR patients and is intended to improve patient outcomes and provide physicians more options to treat their patients.

Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.

Strategic Device Partnership Allows Seelos to Use Aptar Pharma's Bidose (BDS) Liquid System Device with the SLS-002 Program (Intranasal Racemic Ketamine). Covers the Use of the BDS Liquid System for Intranasal Delivery of SLS-002 for the Treatment of Suicidality, Major Depressive Disorder and PTSD, and Agreement Provides Other Rights to Include Additional Undisclosed Indications

IRRAS Announces Collaboration with Aarhus University Hospital a Leading Medical Institution

The collaboration with Aarhus University's neurosurgical team will evaluate IRRAflow during the treatment of Intraventricular Hemorrhage (IVH) and assessment of brain compliance

LimaCorporate Reports the Successful Completion of the 1st Total Shoulder Arthroplasty Using the Smart Space Cubit Intraoperative Guidance System

I was impressed with the seamless and efficient integration of the instrumentation into my normal procedural workflow, resulting in minimal deviations from normal technique and no additional procedural time said Shelden Martin, MD.
Exit mobile version